NDC 71205-831 – Lubiprostone

Lubiprostone 8 ug/1 · Capsule, Gelatin Coated · Oral

Human Prescription Drug

Product NDC71205-831

Product details

Brand name
Lubiprostone
Generic name
Lubiprostone
Labeler
Proficient Rx LP
Dosage form
Capsule, Gelatin Coated
Route
Oral
Marketing category
NDA AUTHORIZED GENERIC · NDA021908
Marketed since
January 1, 2023
Listing expires
December 31, 2026
Pharmacologic class
Chloride Channel Activator

Active ingredients

Uses, dosage, side effects and warnings for Lubiprostone →

Package NDC codes (10)

Package NDCDescriptionSince
71205-831-00100 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-00)Oct 18, 2023
71205-831-111000 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-11)Oct 18, 2023
71205-831-3030 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-30)Oct 18, 2023
71205-831-55500 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-55)Oct 18, 2023
71205-831-6060 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-60)Oct 18, 2023
71205-831-64240 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-64)Oct 18, 2023
71205-831-67270 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-67)Oct 18, 2023
71205-831-72120 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-72)Oct 18, 2023
71205-831-78180 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-78)Oct 18, 2023
71205-831-9090 CAPSULE, GELATIN COATED in 1 BOTTLE (71205-831-90)Oct 18, 2023

Other Lubiprostone products